This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sleep Apnea Treatment Centers Of America Offers Rescue To Sleep Medicine Doctors

TAMPA, Fla., Feb. 12, 2013 /PRNewswire/ -- Sleep doctors around the country have awoken to news of shrinking reimbursement rates for the diagnosis and treatment of sleep related breathing disorders . Sleep Apnea Treatment Centers of America (SATCOA), the pioneer of an office-based, obstructive sleep apnea treatment, offers a business opportunity to help Pulmonologists, ENT's and other sleep medicine focused physicians regain their previously strong streams of revenue while offering a great alternative for treatment and a possible cure to their patients.  

In the past, physicians affiliated with sleep clinics were seeing hefty reimbursements from insurance carriers. Medicare spending alone on in clinic-sleep diagnostic studies increased 580% in just nine years' time, to $415 million in 2010, according to a report from the US Office of the Inspector General. This rapid increase proved to be unsustainable.

In the present, Medicare along with other private payers are pushing for less-expensive, at home sleep testing that allows patients to bypass a sleep clinic for their diagnostic studies. This is leaving many sleep doctors without a stream of revenue that was common in the field of sleep medicine. Consequently, New England based sleep clinic, Sleep HealthCenters, filed for bankruptcy and abruptly closed all of its 19 locations in January. This is one of many examples that we are seeing fall victim to this drastic change in reimbursement policy.

SATCOA brings balance back to the field of sleep medicine and allows its physicians to offer a curative, highly-reimbursable treatment option for those patients suffering with sleep apnea while replacing lost revenue from the at-home-sleep study movement. Founder and CEO of Sleep Apnea Treatment Centers of America, Dr. Jeffery Silveira has said, "Sleep physicians will have to hold back on their practice and lab expansion. This will result in a significant cut back on the number of labs across the country. Business as usual will simply not survive without innovation and substantive change."

About Sleep Apnea Treatment Centers of America: 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs